-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Xylem, Raises Price Target to $159

Benzinga·07/29/2026 12:55:52
Listen to the news
Barclays analyst William Grippin maintains Xylem (NYSE:XYL) with a Overweight and raises the price target from $154 to $159.